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Polymeric nanoparticles have been the focus for nanocarrier preparation in numerous biomedical applications such as 
cancer treatment, disease diagnosis, vaccination, in the last two decades. They have been variably surface modified using 
copolymers, Polyethylene glycol (PEG), dextran, cyclodextrin, cytokines, small molecules to improve their efficiency and 
efficacy. The resulting nano-formulations include polymer-protein conjugate, polymeric micelle, polymer-small molecule 
conjugate, dendrimer, polymeric vesicles, nano-hybrids, hydrogels etc. These may have intrinsic immunogenicity and require 
accurate characterization in order to improve their pharmacological targeting, pharmacokinetic profiles and to reduce adverse 
reactions. Therefore, we have reviewed the polymeric nanoparticles and the electron microscopy techniques available for their 
characterization in the context of their surface modifications and functionalization. 
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The nanocarriers available for biomedical use include; 
polymers, lipid carriers (liposomes/micelles), 
dendrimers, carbon nanotubes, silver, gold 
nanoparticles
1
, quantum dots, organic nanoparticles, 
liposomes etc. Of these, polymers are the most 
common materials used for nanoparticle (NPs) based 
drug formulations (Table 1 & Fig. 1). Polymeric 
nanoparticles (10-1000 nm) are biodegradable, 
biocompatible, non-toxic, non-immunogenic and water 
soluble with potential application in tissue engineering, 
drug and gene delivery, imaging and vaccination 
strategies. Their action has been studied in cancer 
therapy at different steps: (i) immunomodulation; 
(ii) prodrug activation; (iii) anti-sense/ RNAi delivery,
(iv) induction of apoptosis etc
2-4
. Recently the use of
polymeric nanoparticles in vaccine design and delivery
has gained interest (Table 2). Hydrogels embedded
with nanoparticles are also being extensively studied




Polymeric nanoparticles are synthesized by multiple 
methods and influenced by a number of factors such as 
polymer DA, DP (degree of acetylation and 
polymerization), polymer concentration, surfactant 
used, and degree of crosslinking with surfactant. These 
result in enormous variation in NPs size, shape and 
chemical functionality
6
. The polymeric NPs are mainly 
spherical in morphology and comprise of nanocapsules 
and nanospheres
7
. They have been categorized based on 
their origin into: natural polymers such as chitosan
8
, 
gelatin, sodium alginate (Table 1 & Fig. 1) and 
synthetic polymers like PLA (polylactic acid), 
polycyanoacrylate, PLGA {poly(lactide-co-glycolide)}, 
PCL (polycaprolactone), PHBV {poly (3-hydroxybutyric 
acid-co-hydroxyvaleric acid)}
9
, PEI ( polyethylenimine). 
Polymeric NPs are produced by dispersion of preformed 
polymers (e.g., PLA) in an aqueous colloidal suspension 
or by polymerization of monomers (e.g., polyalkyl 
cyanoacrylate)
10
 which allows for insertion of drug 
compounds with greater efficiency
11
. Nanoprecipitation 
is the commonly used method for preparation of both 
nanospheres and nanocapsules
12




The morphology (shape and size) of the polymeric 
nanoparticles is mainly determined by scanning and/or 
transmission electron microscopy (SEM and TEM) 
(Fig. 2). SEM generates visual information on external 
morphology, chemical composition and surface texture 
which is not quantitative. SEM provides limited 
information about size distribution of the particles and 








Table 1 — Types of Polymeric nanoparticles and their surface modifications 
Polymeric NP Surface modifications Size of NP (Diameter) Shape on TEM/SEM References 
Natural Polymers 
Chitosan LMW-PEI linked chitosan  
Chitosan-TPP 
100–250 nm  
100-1200 nm 





Stearyl-grafted chitosan 120-160 nm Spherical [56] 
Gelatin Thiolated/ PEGylated/ Cationized 
Antibody/Peptide/ 
Carbohydrate/Fatty acid coated 
Gelatin methacryloyl (GelMA) 





Nanocapsules, (having a hollow interior 





Sodium alginate Alginate-chitosan NPs 50–80 nm Spherical shape [101] 
Synthetic Polymers 
PLA (polylactic acid) -None- 100 nm Dehydrated hard sphere [102, 9] 
 PEI-coated PLA NPs 115 nm Core shell [103] 
 Lactoferrin (Lf) conjugated  
PEG-PLA–NPs  
131 nm Spherical [104] 
 Polydopamine-modified  
(pD-TPGS-PLA/NPs) 




-None 152.0±58.08 nm Spherical particles with smooth surfaces 
on SEM and core-shell structure on TEM 
[106] 
 Chitosan coated PLGA coated 284 nm Spherical [107] 
 S2P Peptide-PLGA-Maleimide- 
PEG-NPs 
183.3 nm Spherical [108] 
 PLGA–PEG–PLGA 275.3 nm Spherical with smooth surface [109] 
 Gelatin -PLGA composites  160 and 175 μm microsphere [99] 
PCL(polycaprolactone) 
 Chitosan-PCL-NPs 230 nm Spherical [107] 
 mPEG-PCL 36 nm Spherical [110] 
 Polysorbate 80 (PS80)-PCL- NPs 100-200 nm Spherical shaped with coating [111] 




-None- 243-260 nm Core shell shaped spherical structure  
on TEM 
[9] 
 PEGylated PHB– 
sorafenib–doxorubicin NPs 




Injectable and in situ gelling 
hydrogels 
80-120 nm Spherical [113] 
Lipid-polymer 
hybrid NPs  
PLGA–lecithin–DSPE-PEG LPHNs  The lipid component, forms lipid 
“flowers”, with “petals” extruding from 
the polymer core which exhibits “onion” 





DSPE-PEG and DSPE-PCB20 
cationic liposomes 
80 nm Spherical shape [39] 
Branched polymers PEGMA5/DEA95– 
EGDMA15–DDT15 branched star 
shaped copolymers 
10–30 nm Spherical particles [6] 
Glycopolymers di-block copolymers of PEG- FITC 
functionalized gold nanoparticles 
(AuNP) 
7 nm Spherical [77] 
Green NPs AgNPs 20-50 nm Spherical [114] 
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of nanoparticles. It can measure the thickness of 
the nanocapsule wall and is used to distinguish 
between nanocapsules and nanospheres
14
. On TEM, 
nanospheres have a spherical shape, with a solid 
polymeric structure, whereas nanocapsules show a thin 
(about 5 nm) polymeric envelope around an oily core 
(Core-shell structure) (Fig. 2).  
The polymeric nanoformulations undergo surface 
modifications by various covalent and non-covalent 
coupling techniques
15 
which can extend their half-life, 
surface charge and improve drug efficacy. For 
nanospheres, the surface adsorption of drugs allows 
for a higher proportion of atoms to be in direct 
contact with solvents. The core-shell structure, in 
Fig. 1 — Biodegradable polymeric nanoparticles for biomedical use. These include the natural and synthetic polymers 
Fig. 2 (A-H) — Shape and size of polymeric Nanoparticles ranging from 200-500 nm on TEM and their advantages 
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nanocapsules, results in outer surface atoms different 
from those of the interior core in entrapped drug 
formulations. Therefore, in nanocapsules, the dual 
attachment of TNF-α in both the core and the shell 
of NPs is needed for their strong and specific binding 
to TNF receptor-expressing cells
16
. The solvent 
concentration, pH, temperature, and sonication 
additionally tune the morphology of polymer 
nanospheres and capsules
10
. The cationically charged 
polymers (Chitosan and PEI) produce more stable 
complexes during cellular trafficking
1
 with high 
level of transfection efficacy and are widely used 
for nucleic acid delivery in a number of target 
organs
17,18
 (Fig. 3). 
Therefore, characterization of the nanoparticle 
morphology, their surface chemistry and growth kinetics 
by advanced electron microscopic techniques, such as, 
SEM-EDX/SAM {Energy Dispersive X-ray 
Spectroscopy (EDX) and Scanning Auger Microscopy 
(SAM)}, High resolution TEM/SEM (HRTEM, 
HRSEM), liquid TEM, cryo-TEM, which can 
characterize the morphology of NPs as well as their 
elemental-chemical composition are increasing in 
relevance. The utility of these advanced techniques in 
polymeric nanoparticle characterization is reviewed in 
the present paper (Table 2 & Fig. 4). 
Types of Polymeric Nanoparticles 
The polymeric nanoparticles for biomedical use have 
been broadly categorized into matrix-like and reservoir-
type NPs
19
; (i) matrix-like NPs; Nanospheres (50-300 nm 
diameter) have a continuous polymeric matrix (drug can 
be retained inside or adsorbed on the surface) and 
(ii) reservoir type NPs: nanocapsules (100-300 nm),
having central aqueous or oil reservoir and
polymerosomes (60-500 nm)
20
 (Fig. 2). Recently hybrid
polymeric NPs have been designed to improve the
circulation stability and for targeted delivery of
Fig 3 — Biological applications of polymeric nanoparticles 
Table 2 — Polymeric Nanoparticles for vaccine delivery 
S. No Polymer Size (EM/Zetasizer) Disease References 
1. PEG-2000 100-200 nm COVID-19 [115] 
2. PEI-mannose 100 nm HIV [116] 
3. PLGA 164 nm Poultry vaccine [117] 
4. PLGA 200 nm Mycobacterium tuberculosis [118] 
5. PLGA 200 nm H5N1influenza; HIV Helicobacter pylori [119] 
6. PCL-Chitosan 208 nm Hepatitis B [120] 
7. PEG-PLA-PEG 242 nm Hepatitis B [121] 
8. Polyethyleneimine-triethyleneglycol 170 nm HIV Infection [122]
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chemotherapeutic agents using polymeric NPs
21
. 
Currently injectable in-situ gelling hydrogels that  
form highly branched hydrazone cross-linked (poly 
oligoethylene glycol methacrylate, POEGMA) are being 
assessed for biological applications
22,23
. 
Nanospheres are obtained when the active principle 
is dissolved or dispersed in the polymeric solution. 
Nanocapsules are obtained when the drug is previously 
dissolved in an oil, which is then emulsified in the 
organic polymeric solution before the internal phase 
is dispersed in the external phase of the emulsion
24,25
. 
Non-spherical polymeric nanoparticles with exotic 
morphologies, such as worms, vesicles, lamellae, 
framboidal vesicles, jellyfish, and yolk/shell particles, 
have been prepared by controlled radical synthesis 
technique, reversible addition-fragmentation chain-
transfer polymerization
26-28
. The diagrammatic 
representation of these morphologies as seen by TEM 
is given in (Fig. 2). 
Surface modifications of polymeric nanoparticles 
Polymeric NPs are variably classified on the basis 
of their surface modifications into; polymer-protein 















, polymer-polymer NPs, 
polymer-lipid NPs, polymer-metal NPs (Fig.4). 
Polymer-protein conjugations 
Protein–polymer conjugates are widely used as 
therapeutics. These nanosystems are based on drug-
loaded polymeric core and are additionally coated by a 
cross linked bovine serum albumin shell that reduces 
their interactions with serum proteins and macrophages. 
Therefore, these surface modified NPs can show potent 
anticancer activity in vitro and in vivo while not 
exhibiting any toxicity to healthy tissue
21
. The other 
polymeric-protein modified nanoparticles include; 
Zwitterionic polymers, glycopolymers, hydrogels, green 
NPs (Table 1). 
Zwitterionic polymers 
The Zwitterionic polymers include poly 
(carboxybetaine) (pCB) and poly(sulfobetaine) 
(pSB)
36
. These have been proposed as PEG alternatives 
due to their inherently low immunogenicity and high 
resistance to nonspecific protein absorption and 
agglomeration
37,38
. Recently, Li et al., 2015 developed 
zwitterionic poly (carboxybetaine) (pCB) modified 
lipoplexes for the delivery of siRNA therapeutics
39
. 
These PCB plated lipoplexes showed enhanced tumor 
accumulation in vivo while avoiding the ABC 
phenomenon. Zwitterionic polymers can undergo 
pH-responsive surface charge and size variations and 
spontaneously self-assemble to form micelle-like and 




Fig. 4 — Surface modifications of biodegradable polymeric nanoparticles, their properties, morphology and their characterization by 
advanced electron microscopy techniques 
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Hydrogels 
Hydrogels have structural and mechanical similarity 
to the extracellular matrix. These branched polymers 
have secondary polymer chains cross linked to a primary 
backbone, showing a variety of polymer architectures 
such as star, H-shaped, pom-pom, and comb-shaped 
polymers
41
. SEM of the cross linked hydrogels shows a 
cellular structure with macropores of approximately 
1 μm diameter. The topology of the hydrogel depends 
on the molecular shape (e.g. branched or circular 
polymers) polymer sequence, molecular weight, 
architecture, and chain connectivity of the precursor 
polymer
42
. Tuning the precursor polymer branch 
length and density results in single-component 
material with superior elasticity and extensibility 





These nanoparticles show good biocompatibility as 
they are based on amino acid-based block copolymers 
and plant extracts. Green synthesis of metal NPs is 
recently gaining attention as a reliable, sustainable, and 
eco-friendly technique for synthesizing metal/metal 
oxides nanomaterials, hybrid materials, and bio 
inspired materials
44
. For e.g.; the silver and gold NPs 
which were synthesized using chemical methods
45-48
 
are being synthesized using green methods/sources, 
like bacteria, fungi, algae, and plant extracts
44,49
, 
resulting in large-scale production with less 
contamination. These green synthesized-silver 
nanoparticles are 10-30 nm by TEM and SEM/EDS 
(Energy-dispersive spectra) revealed that these 
nanoparticles contain silver in its pure form
50
. 
Polymeric micelles (PMs) 
PMs range from 10 to 100 nm, have a unique core-
shell structure and are used for drug delivery of 
hydrophobic drugs. The inner hydrophobic core 
incorporates the poorly water-soluble drugs and is 
surrounded by hydrophilic shell
51,52
. Polymeric 
micelles are formed by electrostatic interactions, using 
charged block copolymers of oppositely charged 
macromolecules, resulting in the formation of 
micelles
53
. The commonly used core-forming blocks of 
PMs, include poly(propylene oxide) (PPO) which 
belongs to pluronics
54
, poly(esters) such as poly(lactic 
acid) (PLA)
55
, hydrophobic poly(amino acids)
56
, 








Poly(ethylene glycol) (PEG) conjugation is mainly 
used as a hydrophilic block in micelles
60,61
 to improve 
their in vivo stability
62
, increase the half-live of the 
drug in the bloodstream, leading to less frequent 
dosing. PEGylated NPs become hydrophilic and attain 
near-zero zeta potential. PEGylation minimizes the 
attachment of serum proteins such as opsonins that 
confers an increased likelihood of NPs phagocytosis by 
the mononuclear phagocyte system
29
. However, PEG 
immunogenicity is a potential drawback. The anti-PEG 
immune response and formation of anti-PEG 
antibodies not only limits the efficacy of PEGylated 
treatment strategies
63
 but hypersensitivity reaction to 
them, can be life threatening in some cases. This is 
driving the development of PEG alternatives
36
, such as; 
poly (N-vinyl-2-pyrrolidone) (PVP)
64
, poly (glycerols), 
poly (acrylic acid) (PAA)
65
. Modifications of PEG with 
bottle brush architecture/POEGMA are being evaluated 




Polymer-small molecule conjugate 
Polymer-small molecule conjugate used in 
nanomedicines include; N-(2-hydroxypropyl) 
methacrylamide copolymer, poly (glutamic acid), 
dextran, polybutadiene (a bilayer-forming polymer 
that can be cross-linked for enhanced vesicle 
stability)
68
 and cyclodextrin (CD)-based polymers
69,32
. 
The drug is (i) covalently bound to the polymer 
carrier by chemical conjugation (e.g., by hydrazone 
bond) or (ii) non-covalently entrapped using 
physical interaction, solubilisation, or polyionic 
complexation
60
 or via metal-ligand coordination 
interactions
70
. The bio adhesive property of CD may 
facilitate in the drug permeability by increasing contact 
time of drug at surface of the mucosa. It is therefore 





Polymeric vesicle also known as polymersomes, 
are self-assembled from amphiphilic block or graft 
copolymers to form hollow structures surrounded by a 
polymeric bilayer membrane or complicated 
interdigitated and amphiphilic membrane structures
72
. 
Ye, 2014 developed biodegradable polymeric vesicles 
as a nanocarrier system for multimodal bio-imaging 
and anticancer drug delivery. They fabricated 
poly(lactic-co-glycolic acid) (PLGA) vesicles 
encapsulated with inorganic imaging agents of 
superparamagnetic iron oxide nanoparticles (SPION), 
manganese-doped zinc sulfide (Mn:ZnS) quantum 
dots (QDs) and the anticancer drug busulfan
73
. 
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Dendrimer 
Dendrimer are synthetic polymeric macromolecules, 
composed of branched monomers that are 
characterized by low polydispersity and good 
biocompatibility
74
. These are spherical, well-designed 
branching polymers with interior cavities and abundant 
terminal groups on the surface which can form stable 
complexes with drugs, plasmid DNA, oligonucleotides, 
and antibodies
75
. Dendrimers are made from several 
different polymers, including polyamidoamines 
(PAMAMs), Poly (amidoamine-organosilicon) 
dendrimers (PAMAMOS), Poly(propylene imine) 
dendrimers (PPI), chiral dendrimers, liquid crystalline 
dendrimers, – tectodendrimers, hybrid dendrimers 
(Table 4 & Fig. 4), multilingual dendrimers, micellar 
dendrimers
35
. Poly (amidoamine) (PAMAM) dendrimers 
is most commonly used dendrimers. The modifiable 
surface of the dendrimers allows conjugation with 
different molecules, like targeting ligands or drugs. 
Previously, modified PAMAM dendrimers with 
surface amino groups conjugated to folic acids have 
been used for the delivery of methotrexate. 
Lipid Polymer hybrid 
Lipid Polymer hybrid (LPHNP), are hybrid 
nanoparticles, composed of shell and polymer core 
which reduce outward diffusion of the encapsulated 
drug and are emerging in popularity as for drug 
delivery. Their advantages include controllable  
ultra-small particle size
48
, surface functionality, 
extremely high surface area to volume ratio, high drug 
loading, multiple therapeutic drugs, tunable drug 
release and good serum stability
76
. LPHNP are 
commonly formulated using-polymers-PLGA, PCL and  
zwitterionic lipids such as, 1,2-dipalmitoyl-sn- 
glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl- 




. Dave et al., 2017 prepared LPHNP of 
Norfloxacin with polylactic acid and soya lecithin which 
exhibited an average particle size from 178.6 ±  
3.7 nm to 220.8 ± 2.3 nm, and a surface charge 
ranging from +23.4 ± 1.5 mV to +41.5 ± 3.4 mV
80
.  
Characterization of polymeric nanoparticles based 
on electron microscopy techniques 
Scanning electron microscope (SEM) 
SEM analyzes the size, shape and surface 
morphology of the nanoparticles (Table 3 & Fig. 4). 
SEM provides finer surface structure images by 
operating at lower accelerating voltages and is 
advantageous when compared to TEM and cryo-TEM. 
Since the penetration and diffusion area of incident 
electrons is shallow, the number of secondary electrons 
emitted from the surface is maximized compared to 
backscattered electrons generated from within the 
specimen and the surface structures are clearly 
gained
81
. Ethyl acetate (EA), acetone (ACE), and 
dichloromethane (DCM) are organic solvents used to 
produce stable nanoparticles. NPs prepared using these 
solvents have discrete, spherical morphology with 
smooth surface and low porosity on SEM imaging
82
. 
Recent study by Rades et al., 2014, has proven that 
combination of complementary techniques as SEM, 
T-SEM, EDX and scanning Auger microscopy (SAM) 
can be a powerful strategy for comprehensive 




Transmission electron microscopy (TEM) 
TEM analyzes the morphologies of polymeric 
nanoparticles at low-to-medium magnifications 
(Table 3). TEM produces high-resolution, detailed 
images of 1 nanometer in size by using high voltages to 
increase the acceleration speed of electrons, which, pass 
through the sample and increase the image resolution. 
TEM resolution is hampered by spherical and chromatic 
aberrations. TEM investigations are mostly conventional 
and make use of mass-thickness contrast of selectively 
stained polymer samples for image formation. These 
stains include or provide better structural differentiation. 
Special techniques used for polymer imaging, including 
electron diffraction, high-resolution TEM, phase contrast 
transmission electron microscopy, low/high-voltage 
TEM, and scanning- TEM
84
.  
Generally, polymeric NPs smaller than about 
200 nm diameters, are dispersed onto a carbon-coated 
grid for TEM inspection. These are composed of only 
low atomic number elements with similar density. 
Mass-thickness contrast in chemically untreated 
polymers can be caused by varying specimen 
thickness, alternatively, the selective staining of one (or 
more) of the components by a heavy metal oxide is 
required for the TEM examination of block copolymer 
systems. Since the aggregation of NPs can change their 
physical properties, therefore, TEM has been applied to 
characterize the dispersion of NPs after their 
internalization. An additional advantage of TEM is that 
it allows the assessment of the changes of subcellular 
structures caused by the NPs
85
. 
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The main disadvantages of TEM are difficulty in 
quantifying large number of particles, difficulty in 
characterizing very homogenous samples, researcher 
training and image artifacts resulting from specimen 
preparation
85
. Furthermore, traditional TEM cannot be 
used to study the growth of NPs in solution. It is not 
possible to directly correlate diameters by TEM in the 
dry state with hydrodynamic diameters in solution. 




High-resolution TEM (HRTEM) 
HRTEM uses phase-contrast imaging, and 
combines both transmitted and scattered electrons to 
produce the image
86
. HRTEM has become the most 
common technique to characterize the internal 
structure of NPs. For e.g., HRTEM has been used to 
study the effect of ligands in the final structure of 
NPs. HRTEM can give information regarding NP 
growth and structure-related properties. However, 
characterization of NPs is not always feasible by this 
technique. This is caused by the random orientation of 
the crystals relative to the electron source, resulting in 
poor alignment and formation of complex images that 




Cryo transmission allows for the specimen of interest 
to be viewed at cryogenic temperatures (Table 3). 
Cryo-TEM assesses the morphology, two-dimensional 
fluidity, lipid shell in nanoparticles in near-unaltered 
samples in their frozen-native environment by vitrifying 
them at cryogenic temperatures
88
. The morphology and 
volume transitions of thermo-responsive core–shell 
NPs can be imaged by cryo-TEM. cryo-TEM achieves 
sub-nanomolar resolutions of morphology of the 




In 2003, Williamson et al., developed a TEM liquid 
cell using epoxy-sealed silicon nitride (SiN) 
membranes
90
. Liquid TEM allows the characterization 
of NPs within fluids is under constant movement. It 
allows for the tracking of the nanoparticle trajectory 
while this is growing, providing direct observation of the 
Table 3 — Electron microscopy of polymeric nanoparticles 
Technique Information obtained Limitations of Technique References 
SEM Widely used method to (i) detect and define size and size 
distribution of NPs, (ii) To visualize NPs in 3D, their 
dispersion in matrices/supports 
conventional SEM imaging mode cannot 
detect NPs on the back side of the support film 
The lateral resolution of T-SEM is limited to 
NP sizes down to 5–10 nm. 
[85] 
T-SEM-EDX (i) By using transmission in SEM (T-SEM) surface as well as
in depth analysis of NPs is performed, (ii)SEM-EDX/SAM
Energy Dispersive X-ray Spectroscopy (EDX), and Scanning
Auger Microscopy (SAM) characterizes the elemental-
chemical composition of NPs and size of NPs, (iii) It gives
precision in lateral dimensions of NPs
Needs a very high-sensitivity EDS detector 
with a very large active area for 
unambiguous detection of core-shell 
characteristics of silica based NPs. 
[126] 
HRSEM High-resolution SEM(HRSEM) images the morphology of
Au NPs and their dispersion in cells and tissues
It can scale down and study the specific spatial arrangements 
of nanometric elements in their biological context and 
examine the possible interactions between the two 
In biological specimens, metal coating is 
necessary to decrease charging artefacts. 
This increases the risk of radiation damage 
to the samples. 
[85,127] 
TEM Most common technique to (i) define NP size, shape, 
interparticle distance-aggregation state, monodispersity of 
NPs, (ii) characterize nanocomposites (eg. Quantum dots, 
metals and magnetic NPs) and change in their structure by 
change in surface charge, (iii) Characterizes Growth kinetics 
of NPs 
difficulty in quantifying a large number of 
particles or misleading images due to 
orientation effects, aggregation of NPs 
during the drying of the colloid suspension 
[128-130] 
HRTEM High-resolution TEM (HRTEM) additionally (i) characterizes 
the crystal structure of nanoparticles, (ii) It distinguishes 
monocrystalline, polycrystalline and amorphous NPs, (iii) 
characterize polymer nanocomposites (PNCs), (iv) used to 
study NP defects 
HETEM needs high voltage, the resultant 
increased temperature, affects the surface 
quality of the PNC. Therefore, for imaging 
PNCs- SEM provides 3D image and is 
preferred 
[131,132] 
Liquid TEM Depicts NP growth in real time, Characterises Growth 
kinetics of NPs 
studies single particle motion, super lattice 
formation 
[133] 
Cryo-TEM Characterises Growth kinetics of NPs, their mechanisms, 
aggregation pathways 
It avoids the development of artefacts or 
destroyed samples 
[134]
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nanoparticle evolution. However, it suffers from lower 
image resolution, due to the SiN membrane and liquid 




The polymeric nanoparticles are biodegradable and 
have half-life based on its interaction with biological 
system. This interaction is defined by their size, 
morphology and unique set of physical (optical, 
magnetic, electronic and catalytic) and chemical 
properties (pH, surface charge)
92-97
. These properties 
significantly contribute to their pharmacological 
targeting, their pharmacokinetics in the body, by 
influencing various physicochemical mechanisms 
such as their diffusivity, interactions with biological 
materials, internalization by cells, functionalization 
etc. Thus emphasizing, the need for a meticulous 
characterization of newly synthesized polymeric 
nanoparticles by advanced electron microscopy 
techniques such as scanning electron microscopy 
(SEM), transmission electron microscopy (TEM), 
Transmission scanning electron microscopy (T-SEM), 
High-resolution SEM (HRSEM), High-resolution 
TEM (HRTEM), scanning TEM (STEM), liquid 
TEM, cryo-TEM.  
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